Reverse T3 is a biologically inactive product of T4 metabolism. Instead of removing an iodine atom to make active T3, the body can remove a different one to make reverse T3. That pathway increases during illness, starvation, surgery and stress. Measuring it has become popular in wellness practice, where a high reverse T3 or a low T3 to reverse T3 ratio is presented as proof of hidden hypothyroidism. Major thyroid societies do not accept that interpretation.

What the American Thyroid Association says

The position is unusually blunt for a guideline body. On its thyroid function tests page the American Thyroid Association states: "In healthy, non-hospitalized people, measurement of reverse T3 does not help determine whether hypothyroidism exists or not, and is not clinically useful." The American Thyroid Association 2014 hypothyroidism guideline does not use reverse T3 to diagnose or to guide dosing, and neither does the joint consensus document on combination therapy.

Why the test cannot do what is claimed

Reverse T3 rises as a normal adaptation, most reliably in non-thyroidal illness. In a hospitalised, critically ill patient, a high reverse T3 with a low T3 is a recognised pattern that reflects severity of illness rather than thyroid failure, and treating it with thyroid hormone has not improved outcomes. In an outpatient who feels tired, a reverse T3 value cannot distinguish an adaptive response from anything else, because there is no validated reference range for symptom prediction and no trial showing that acting on the number helps.

The cost of ordering it anyway

An abnormal-looking result on a test that does not mean anything still leads somewhere. In practice it leads to liothyronine or desiccated thyroid prescribed to a person with normal thyroid function, which suppresses TSH and carries genuine risk of atrial fibrillation and bone loss. It also delays the search for the actual cause of fatigue.

Claim made about reverse T3	Status
High reverse T3 proves cellular or tissue hypothyroidism	Contested and unsupported; no society endorses it
The T3 to reverse T3 ratio should guide dosing	No validated cut-off, no outcome trial
Reverse T3 rises in serious illness and starvation	True, and a marker of illness severity rather than thyroid disease
Reverse T3 belongs on a routine thyroid panel	Not recommended by the American Thyroid Association

If a reverse T3 has already been ordered and came back high, ask what would be done differently if it were normal. If the answer is nothing, the result can be set aside. The productive next tests for unexplained fatigue with a normal TSH are ferritin, B12, vitamin D, HbA1c and a sleep apnoea screen.

Reverse T3, or 3,3',5'-triiodothyronine, is produced by type 3 deiodinase and cleared by type 1 deiodinase. Both enzymes shift during fasting, sepsis, trauma, cardiac surgery and glucocorticoid or amiodarone exposure, which is why reverse T3 tracks illness severity in intensive care populations.

Assay performance is a separate problem: reverse T3 immunoassays are poorly standardised, cross-react with T4 and T3, and reference intervals vary widely between laboratories, so results are not comparable across methods. There is no randomised evidence that treatment guided by reverse T3 or by a T3 to reverse T3 ratio improves symptoms or outcomes. Where non-thyroidal illness syndrome is genuinely suspected in a hospitalised patient, the management is to treat the underlying illness and repeat thyroid function tests after recovery.

Sources

What the American Thyroid Association says

Why the test cannot do what is claimed

The cost of ordering it anyway

Sources

Related